Le Lézard
Classified in: Covid-19 virus
Subjects: SVY, MAT, MRR

Nicotine gum market size to grow by USD 1.01 billion from 2020 to 2025: A descriptive analysis of customer landscape, vendor assessment, and market dynamics - Technavio


NEW YORK, Jan. 23, 2023 /PRNewswire/ -- The global nicotine gum market size is estimated to increase by USD 1.01 billion from 2020 to 2025. However, the market's growth momentum will decelerate at a CAGR of 4.43% during the forecast period. The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies, growth strategies, product innovations, new product launches, investments, and growth in market share, among others ? Buy the report!

Global nicotine gum market - Customer landscape
To help companies evaluate and develop growth strategies, the report outlines ?

Global nicotine gum market ? Vendor analysis
Vendor landscape ?

The global nicotine gum market is fragmented, with the presence of several international and domestic vendors. A few prominent vendors that offer nicotine gum in the market are British American Tobacco Plc, Cambrex Corp., Cipla Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., ITC Ltd., Johnson and Johnson Inc., Lil Drug Store Products Inc., Major Pharmaceuticals Inc., Walgreen Co., and others.

The market is subject to rapidly changing consumer demands and preferences. Vendors in the market compete on several factors, such as quality, price, service, brand image, distribution, and marketing. Moreover, major vendors are focusing on acquiring smaller brands to increase their market presence.

Vendor offerings -

Global nicotine gum market - Segmentation assessment

Segment overview
Technavio has segmented the market based on product (2-mg nicotine and 4-mg nicotine). 

Geography overview
Based on geography, the global nicotine gum market is segmented into North America, Europe, APAC, South America, and MEA. The report provides actionable insights and estimates the contribution of all regions to the growth of the global nicotine gum market.

Download a sample report

Global nicotine gum market ? Market dynamics

Leading drivers - The increasing number of people trying to quit smoking is driving the nicotine gum market growth. Many people across the world are trying to quit smoking with the help of various smoking cessation aids, such as e-cigarettes and nicotine gum. Public awareness programs and campaigns are being conducted across the world to encourage people to stop smoking. For instance, the World Health Organization (WHO) observes May 31st of every year as World No Tobacco Day. Similarly, Campaign for Tobacco-Free Kids helps people reduce tobacco use. Such awareness programs are expected to fuel the market growth during the forecast period.

Key trends ? The launch of new products is a key trend in the market. Successful product launches increase the revenue inflow and market share of players. They also retain the interest of consumers in the market. For instance, in February 2020, Lucy goods launched a new nicotine gum product with cinnamon fruit and mint flavor in California, US. Such product launches will support the nicotine gum market growth during the forecast period.

Major challenges - Health issues associated with smoking cessation products are challenging the nicotine gum market growth. Long-term use of nicotine gums can lead to health issues such as hair loss and skin irritation. In addition, users of nicotine gums are at a higher risk of heart palpitations and chest pain. Such health issues may impede the market growth during the forecast period.

Drivers, trends, and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report!

What are the key data covered in this nicotine gum market report?

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

The functional chewing gum market is estimated to grow at a CAGR of 5.25% between 2022 and 2027. The size of the market is forecasted to increase by USD 2,828.5 million. This report extensively covers market segmentation by distribution channel (convenience stores, hypermarkets and supermarkets, and online), product (oral health gum, nicotine gum, weight gum, and lifestyle gum), and geography (APAC, Europe, North America, Middle East and Africa, and South America).

The energy gum market size is expected to increase by USD 50.48 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 8.74%. This report extensively covers energy gum market segmentation by distribution channel (offline and online) and geography (North America, Europe, APAC, South America, and the Middle East and Africa).

Nicotine Gum Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Decelerate at a CAGR of 4.43%

Market growth 2021-2025

USD 1.01 billion

Market structure

Fragmented

YoY growth 2020-2021 (%)

4.85

Regional analysis

North America, Europe, APAC, South America, and MEA

Performing market contribution

North America at 31%

Key countries

US, Germany, France, China, and UK

Competitive landscape

Leading vendors, market positioning of vendors, competitive strategies, and industry risks

Key companies profiled

British American Tobacco Plc, Cambrex Corp., Cipla Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., ITC Ltd., Johnson and Johnson Inc., Lil Drug Store Products Inc., Major Pharmaceuticals Inc., and Walgreen Co.

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio's consumer staples market reports

Table of contents

1. Executive Summary 

  1.1 Market Overview

  Exhibit 01:  Key Finding 1

  Exhibit 02:  Key finding 2

  Exhibit 03:  Key finding 3

  Exhibit 04:  Key finding 5

  Exhibit 05:  Key finding 6

  Exhibit 06:  Key Finding 7

  Exhibit 07:  Key Finding 8

2. Market Landscape 

  2.1 Market ecosystem 

  2.1.1 Parent market

  Exhibit 08:  Parent market

  Exhibit 09:  Market characteristics

  2.2 Value chain analysis 

  Exhibit 10:  Value chain analysis: Tobacco market

  2.2.1 Inputs

  2.2.2 Inbound logistics

  2.2.3 Operations

  2.2.4 Outbound logistics

  2.2.5 Marketing and sales

  2.2.6 Support activities

  2.2.7 Innovations

3. Market Sizing 

  3.1 Market definition

  Exhibit 11:  Offerings of vendors included in the market definition

  3.2 Market segment analysis 

  Exhibit 12:  Market segments

  3.3 Market size 2021 

  3.4 Market outlook: Forecast for 2021 - 2025 

  3.4.1 Estimating growth rates for emerging and high-growth markets

  3.4.2 Estimating growth rates for mature markets

  Exhibit 13:  Global - Market size and forecast 2020 - 2025 ($ million)

  Exhibit 14:  Global market: Year-over-year growth 2020 - 2025 (%)

4. Five Forces Analysis 

  4.1 Five Forces Summary 

  Exhibit 15:  Five forces analysis 2020 & 2025

  4.2 Bargaining power of buyers 

  Exhibit 16:  Bargaining power of buyers

  4.3 Bargaining power of suppliers 

  Exhibit 17: Bargaining power of suppliers

  4.4 Threat of new entrants 

  Exhibit 18:  Threat of new entrants

  4.5 Threat of substitutes 

  Exhibit 19: Threat of substitutes

  4.6 Threat of rivalry 

  Exhibit 20: Threat of rivalry

  4.7 Market condition

  Exhibit 21:  Market condition - Five forces 2020

5. Market Segmentation by Product 

  5.1 Market segments

  The segments covered in this chapter are:

  Exhibit 22:  Product - Market share 2021-2025 (%)

  5.2 Comparison by Product 

  Exhibit 23:  Comparison by Product

  5.3 2-mg nicotine - Market size and forecast 2020-2025 

  Exhibit 24:  2-mg nicotine - Market size and forecast 2020-2025 ($ million)

    Exhibit 25:  2-mg nicotine - Year-over-year growth 2020-2025 (%)

  5.4 4-mg nicotine - Market size and forecast 2020-2025 

  Exhibit 26:  4-mg nicotine - Market size and forecast 2020-2025 ($ million)

  Exhibit 27:  4-mg nicotine - Year-over-year growth 2020-2025 (%)

  5.5 Market opportunity by Product 

  Exhibit 28:  Market opportunity by Product

6. Customer landscape 

  Technavio's customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria

  6.1 Overview

  Exhibit 29:  Customer landscape

7. Geographic Landscape 

  7.1 Geographic segmentation

  The regions covered in the report are:

  Exhibit 30:  Market share by geography 2020-2025 (%)

  7.2 Geographic comparison 

  Exhibit 31:  Geographic comparison

  7.3 North America - Market size and forecast 2020-2025 

  Exhibit 32:  North America - Market size and forecast 2020-2025 ($ million)

  Exhibit 33:  North America - Year-over-year growth 2020-2025 (%)

  7.4 Europe - Market size and forecast 2020-2025 

  Exhibit 34:  Europe - Market size and forecast 2020-2025 ($ million)

  Exhibit 35:  Europe - Year-over-year growth 2020-2025 (%)

  7.5 APAC - Market size and forecast 2020-2025 

  Exhibit 36:  APAC - Market size and forecast 2020-2025 ($ million)

  Exhibit 37:  APAC - Year-over-year growth 2020-2025 (%)

  7.6 South America - Market size and forecast 2020-2025 

  Exhibit 38:  South America - Market size and forecast 2020-2025 ($ million)

  Exhibit 39:  South America - Year-over-year growth 2020-2025 (%)

  7.7 MEA - Market size and forecast 2020-2025 

  Exhibit 40:  MEA - Market size and forecast 2020-2025 ($ million)

  Exhibit 41:  MEA - Year-over-year growth 2020-2025 (%)

  7.8 Key leading countries 

  Exhibit 42:  Key leading countries

  7.9 Market opportunity by geography

  Exhibit 43:  Market opportunity by geography ($ million)

8. Drivers, Challenges, and Trends 

  8.1 Market drivers 

  8.1.1 Increasing number of people trying to quit smoking

  8.1.2 Increasing awareness about the harmful effects of cigarette smoking

  8.1.3 Growing enrolment in smoking cessation therapies

  8.2 Market challenges 

  8.2.1 Health issues associated with smoking cessation products

  8.2.2 Increasing use of e-cigarettes among teenagers

  8.2.3 Presence of substitute products

  8.2.4 Stringent regulations

  Exhibit 44:  Impact of drivers and challenges

  8.3 Market trends 

  8.3.1 New product launch

  8.3.2 Addiction to nicotine gums

  8.3.3 Increasing awareness regarding health hazards associated with smoking

9. Vendor Landscape 

  9.1 Overview

  Exhibit 45:  Vendor landscape

  9.2 Landscape disruption 

  Exhibit 46:  Landscape disruption

  Exhibit 47:  Industry risks

  9.3 Competitive scenario 

10. Vendor Analysis 

  10.1 Vendors covered 

  Exhibit 48:  Vendors covered

  10.2 Market positioning of vendors 

  Exhibit 49: Market positioning of vendors

  10.3 British American Tobacco Plc 

  Exhibit 50:  British American Tobacco Plc - Overview

  Exhibit 51:  British American Tobacco Plc - Business segments

  Exhibit 52:  British American Tobacco Plc - Key offerings

  Exhibit 53:  British American Tobacco Plc - Segment focus

  10.4 Cambrex Corp. 

  Exhibit 54:  Cambrex Corp. - Overview

  Exhibit 55:  Cambrex Corp. - Product and service

  Exhibit 56:  Cambrex Corp. - Key offerings

  10.5 Cipla Inc.

  Exhibit 57:  Cipla Inc. - Overview

  Exhibit 58:  Cipla Inc. - Business segments

  Exhibit 59:  Cipla Inc. - Key offerings

  Exhibit 60:  Cipla Inc. - Segment focus

  10.6 GlaxoSmithKline Plc 

  Exhibit 61:  GlaxoSmithKline Plc - Overview

  Exhibit 62:  GlaxoSmithKline Plc - Business segments

  Exhibit 63:  GlaxoSmithKline Plc - Key offerings

  Exhibit 64:  GlaxoSmithKline Plc - Segment focus

  10.7 Glenmark Pharmaceuticals Ltd. 

  Exhibit 65:  Glenmark Pharmaceuticals Ltd. - Overview

  Exhibit 66:  Glenmark Pharmaceuticals Ltd. - Business segments

  Exhibit 67:  Glenmark Pharmaceuticals Ltd. - Key offerings

  Exhibit 68:  Glenmark Pharmaceuticals Ltd. - Segment focus

  10.8 ITC Ltd.

  Exhibit 69:  ITC Ltd. - Overview

  Exhibit 70:  ITC Ltd. - Business segments

  Exhibit 71:  ITC Ltd. - Key offerings

  Exhibit 72:  ITC Ltd. - Segment focus

  10.9 Johnson and Johnson Inc.  

  Exhibit 73:  Johnson and Johnson Inc.  - Overview

  Exhibit 74:  Johnson and Johnson Inc.  - Business segments

  Exhibit 75:  Johnson and Johnson Inc.  - Key offerings

  Exhibit 76:  Johnson and Johnson Inc.  - Segment focus

  10.10 Lil Drug Store Products Inc. 

  Exhibit 77:  Lil Drug Store Products Inc. - Overview

  Exhibit 78:  Lil Drug Store Products Inc. - Product and service

  Exhibit 79:  Lil Drug Store Products Inc. - Key offerings

  10.11 Major Pharmaceuticals Inc. 

  Exhibit 80:  Major Pharmaceuticals Inc. - Overview

  Exhibit 81:  Major Pharmaceuticals Inc. - Product and service

  Exhibit 82:  Major Pharmaceuticals Inc. - Key offerings

  10.12 Walgreen Co. 

  Exhibit 83:  Walgreen Co. - Overview

  Exhibit 84:  Walgreen Co. - Product and service

  Exhibit 85:  Walgreen Co. - Key offerings

11. Appendix 

  11.1 Scope of the report 

  11.1.1 Market definition

  11.1.2 Objectives

  11.1.3 Notes and caveats

  11.2 Currency conversion rates for US$ 

  Exhibit 86:  Currency conversion rates for US$

  11.3 Research Methodology 

  Exhibit 87:  Research Methodology

  Exhibit 88:  Validation techniques employed for market sizing

  Exhibit 89:  Information sources

  11.4 List of abbreviations 

  Exhibit 90:  List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
Newsroom: https://newsroom.technavio.org/news/nicotine-gummarket

SOURCE Technavio


These press releases may also interest you

at 17:50
The global feminine hygiene wash market  size is estimated to grow by USD 124.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 5.17%  during the forecast period.  Advertising and promotion of...

at 17:30
The global marine loading arms market size is estimated to grow by USD 65.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 3.43%  during the forecast period. Rise in demand for oil and gas...

at 17:01
The global payment gateways market size is estimated to grow by USD 11.23 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 13.42%  during the forecast period.  High adoption of contactless payment...

at 16:50
The global wellness real estate market size is estimated to grow by USD 1.26 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 32.14% during the forecast period. Rising demand for wellness real estate from...

at 16:35
Navidea Biopharmaceuticals, Inc. ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced disappointing results of an exploratory analysis conducted on the...

at 16:10
The global consumer healthcare market size is estimated to grow by USD 170.2 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 6.78% during the forecast period. Awareness about lifestyle diseases is driving...



News published on and distributed by: